Wisconsin man dies after inhaler cost jumps $500, according to family's lawsuit
A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a ...
Managed Healthcare Executive24d
Wezlana, First Stelara Biosimilar To Hit the Market, Available Only Through Optum's Nuvaila
Without a lot of fanfare or a news release, Wezlana (ustekinumab-auub), the first Stelara (ustekinumab) biosimilar has hit the market but only through a biosimilar procurement business of Optum, a ...